TSE:EXE Extendicare (EXE) Stock Price, News & Analysis C$7.71 +0.07 (+0.92%) (As of 07/26/2024 ET) Add Compare Share Share Today's RangeC$7.59▼C$7.7350-Day RangeC$7.15▼C$7.8752-Week RangeC$5.75▼C$8.04Volume97,267 shsAverage Volume120,156 shsMarket CapitalizationC$642.86 millionP/E Ratio18.80Dividend Yield6.23%Price TargetC$8.33 Stock AnalysisStock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsHeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsHeadlines Get Extendicare alerts: Email Address Extendicare MarketRank™ Stock AnalysisAnalyst RatingModerate Buy2.50 Rating ScoreUpside/Downside8.1% UpsideC$8.33 Price TargetShort InterestN/ADividend StrengthWeakBased on Four FactorsSustainabilityN/ANews SentimentN/AInsider TradingN/AProj. Earnings GrowthN/ASee Full Details Hide Full Details Overall MarketRank™New Rank-Based ScoringMarketRank™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.0.58 out of 5 stars 1.3 Analyst's Opinion Consensus RatingExtendicare has received a consensus rating of Moderate Buy. The company's average rating score is 2.50, and is based on 2 buy ratings, 2 hold ratings, and no sell ratings.Amount of Analyst CoverageExtendicare has only been the subject of 2 research reports in the past 90 days.Read more about Extendicare's stock forecast and price target. Previous Next N/A Short Interest Short InterestThere is no current short interest data available for EXE. Previous Next 1.7 Dividend Strength Dividend LeadershipExtendicare is a leading dividend payer. It pays a dividend yield of 6.44%, putting its dividend yield in the top 25% of dividend-paying stocks.Dividend GrowthExtendicare does not have a long track record of dividend growth.Dividend CoverageThe dividend payout ratio of Extendicare is 117.07%. Payout ratios above 75% are not desirable because they may not be sustainable.Read more about Extendicare's dividend. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for EXE. Previous Next 2.4 News and Social Media Coverage News SentimentExtendicare has a news sentiment score of 0.30. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.61 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 1 news article for Extendicare this week, compared to 0 articles on an average week.Search InterestOnly 1 people have searched for EXE on MarketBeat in the last 30 days. This is a decrease of 0% compared to the previous 30 days.MarketBeat Follows3 people have added Extendicare to their MarketBeat watchlist in the last 30 days. Previous Next 0.8 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Extendicare insiders have not sold or bought any company stock.Percentage Held by Insiders13.92% of the stock of Extendicare is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by InstitutionsOnly 20.15% of the stock of Extendicare is held by institutions.Read more about Extendicare's insider trading history. Previous Next 1.3 Earnings and Valuation Price to Earnings Ratio vs. the MarketThe P/E ratio of Extendicare is 18.80, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 142.60.Price to Earnings Ratio vs. SectorThe P/E ratio of Extendicare is 18.80, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 155.18.Price to Book Value per Share RatioExtendicare has a P/B Ratio of 7.01. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.Read more about Extendicare's valuation and earnings. Previous Next See Top Rated MarketRank™ Stocks Here Ad Porter & CompanyObama wins Presidential debate When I said Obama would seek a third term… They called me a conspiracy theorist, they said it couldn’t happen, that the 22nd Amendment makes it impossible. But as I explained on live radio years ago, “he could have a proxy… while he remains in control of the administration much like Putin did in Russia.” Please, watch this now before it’s too late. About Extendicare Stock (TSE:EXE)Extendicare Inc., through its subsidiaries, provides care and services for seniors in Canada. The company offers long term care (LTC) services; and home health care services, such as nursing care, occupational, physical and speech therapy, and assistance with daily activities, as well as management, consulting, and other services to third parties. It operates through the Extendicare, ParaMed, Extendicare Assist, and SGP Purchasing Partner Network brands. The company was incorporated in 1968 and is based in Markham, Canada.Read More EXE Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart EXE Stock News HeadlinesJuly 19, 2024 | theglobeandmail.comClosing Bell: Extendicare Inc flat on Wednesday (EXE)July 16, 2024 | americanbankingnews.comExtendicare Inc. Plans Monthly Dividend of $0.04 (TSE:EXE)July 26, 2024 | InvestorPlace (Ad)Breaking News: Elon Musk Invents New Type of A.I. (Shocking)Could Elon's New Device be Bigger than the iPhone? According to 30-year Silicon Valley and Wall Street veteran, Eric Fry… This mind-blowing new technology could be bigger than the iPhone.May 22, 2024 | msn.comDividend Investors Can Earn $500 Every Month or More With the Right Stock Offering a 6% YieldMay 6, 2024 | finance.yahoo.comThose who invested in Extendicare (TSE:EXE) a year ago are up 18%April 30, 2024 | finance.yahoo.comAlayaCare Selected by ParaMed as Technology Platform to Power Home Health Care Across CanadaApril 9, 2024 | theglobeandmail.comContra Guys: As seniors’ population rises, Extendicare worth a lookApril 8, 2024 | finance.yahoo.comCan Extendicare Inc. (TSE:EXE) Maintain Its Strong Returns?July 26, 2024 | InvestorPlace (Ad)Breaking News: Elon Musk Invents New Type of A.I. (Shocking)Could Elon's New Device be Bigger than the iPhone? According to 30-year Silicon Valley and Wall Street veteran, Eric Fry… This mind-blowing new technology could be bigger than the iPhone.April 4, 2024 | theglobeandmail.comExtendicare Announces Timing of 2024 First Quarter Results and Conference CallApril 4, 2024 | finance.yahoo.comExtendicare Announces Timing of 2024 First Quarter Results and Conference CallMarch 20, 2024 | fool.caInvest $374.50 Each Month to Create Passive Income of $288 in 2024March 10, 2024 | seekingalpha.comExtendicare Inc. (EXETF) Q4 2023 Earnings Call TranscriptMarch 8, 2024 | finanznachrichten.deExtendicare Inc: Extendicare Announces 2023 Fourth Quarter and Year End ResultsMarch 8, 2024 | msn.comExtendicare GAAP EPS of C$0.10, revenue of C$350.18MFebruary 20, 2024 | finance.yahoo.comIs Now An Opportune Moment To Examine Extendicare Inc. (TSE:EXE)?February 15, 2024 | finance.yahoo.comExtendicare Opens the MarketJanuary 19, 2024 | finance.yahoo.comExtendicare Announces Timing of 2023 Fourth Quarter Results and Conference CallSee More Headlines Receive EXE Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Extendicare and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings5/15/2024Ex-Dividend for 7/15 Dividend6/28/2024Dividend Payable7/15/2024Today7/26/2024Ex-Dividend for 8/15 Dividend7/31/2024Next Earnings (Confirmed)8/12/2024Dividend Payable8/15/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeTSE SectorMedical Industry Medical Care Facilities Sub-IndustryN/A Current SymbolTSE:EXE CUSIPN/A CIKN/A Webwww.extendicare.com Phone905-470-4000FaxN/AEmployees23,000Year FoundedN/APrice Target and Rating Average Stock Price TargetC$8.33 High Stock Price TargetC$8.50 Low Stock Price TargetC$8.00 Potential Upside/Downside+8.1%Consensus RatingModerate Buy Rating Score (0-4)2.50 Research Coverage4 Analysts Profitability EPS (Most Recent Fiscal Year)C$0.41 Trailing P/E Ratio18.80 Forward P/E Ratio16.45 P/E GrowthN/ANet IncomeC$35.50 million Net Margins2.63% Pretax MarginN/A Return on Equity37.03% Return on Assets6.73% Debt Debt-to-Equity Ratio365.69 Current Ratio0.82 Quick Ratio0.98 Sales & Book Value Annual SalesC$1.35 billion Price / Sales0.48 Cash FlowC$2.41 per share Price / Cash Flow3.20 Book ValueC$1.10 per share Price / Book7.01Miscellaneous Outstanding Shares83,380,000Free FloatN/AMarket CapC$642.86 million OptionableNot Optionable Beta1.23 7 AI Stocks to Invest In: An Introduction to AI Investing For Self-Directed InvestorsAs the AI market heats up, investors who have a vision for artificial intelligence have the potential to see real returns. Learn about the industry as a whole as well as seven companies that are getting work done with the power of AI.Get This Free Report Key ExecutivesDr. Michael R. Guerriere M.D. (Age 59)MBA, CEO, President & Director Comp: $1.21MMr. David E. BaconSenior VP & CFOJoe BelinskyVP of Information Technology & Chief Information OfficerMs. Jillian E. FountainVice President of Investor RelationsMs. Kathryn Killoran BradleyVice President of Corporate DevelopmentMs. Katie LeMoyneSenior VP & Chief Human Resources OfficerMs. Wendy GilmourSenior Vice President of Long-term Care OperationsMs. Amie Cathleen VahrmeyerVice President of Long-Term Care Operations for ONMore ExecutivesKey CompetitorsdentalcorpTSE:DNTLWELL Health TechnologiesTSE:WELLSienna Senior LivingTSE:SIAMedical FacilitiesTSE:DRKDA GroupCVE:KDAView All Competitors EXE Stock Analysis - Frequently Asked Questions How have EXE shares performed this year? Extendicare's stock was trading at C$7.28 on January 1st, 2024. Since then, EXE stock has increased by 5.9% and is now trading at C$7.71. View the best growth stocks for 2024 here. How were Extendicare's earnings last quarter? Extendicare Inc. (TSE:EXE) released its earnings results on Wednesday, May, 15th. The company reported $0.14 earnings per share for the quarter. The firm had revenue of $367.10 million for the quarter, compared to the consensus estimate of $310 million. Extendicare had a trailing twelve-month return on equity of 37.03% and a net margin of 2.63%. How do I buy shares of Extendicare? Shares of EXE stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.Compare Top Brokerages Here. What other stocks do shareholders of Extendicare own? Based on aggregate information from My MarketBeat watchlists, some other companies that Extendicare investors own include Inter Pipeline (IPL), Pembina Pipeline (PPL), BCE (BCE), Chorus Aviation (CHR), Cenovus Energy (CVE), Medical Facilities (DR) and Martinrea International (MRE). This page (TSE:EXE) was last updated on 7/26/2024 by MarketBeat.com Staff From Our Partners625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | Sponsored“Generational Bull Run” IncomingLIVE Cash Flow Workshop Event / Hosted Virtually Weds @ 7PM EST Everyone who attends will also receive 3 sp...Unstoppable Prosperity | SponsoredRare signal predicts 50% market drop - before electionThe market is near all-time highs, we're told that unemployment is low, AI's a gift to humanity, and the FED w...Behind the Markets | SponsoredThis student turned $1,300 into $45,000 in just 4 Months!With the help of S.A.M. (my new AI-powered scanner) it's now easier than ever to find these unique trades... ...Monument Traders Alliance | SponsoredBreaking News: Elon Musk Invents New Type of A.I. (Shocking)Could Elon's New Device be Bigger than the iPhone? According to 30-year Silicon Valley and Wall Street vete...InvestorPlace | SponsoredCollapse of the PetrodollarThe death of the "petrodollar" seems imminent. And the implications could not be worse for Americans. Ru...Colonial Metals | SponsoredFormer Hedge Fund Manager Issues Crash PredictionOur No. 1 stock for the rare "millionaire window" opening NOW According to Wall Street legend Whitney Tilso...Stansberry Research | SponsoredBrace Yourself: Experts calling for Bitcoin to hit $100kFor the past few months, Bitcoin has been trading flat… It's been stuck around the $60,000 to $72,000 range...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Extendicare Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Extendicare With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free EXE Stock Alerts